Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

38.97 40.30 23.94 20.93
P/S ratio
0.19 0.20 0.19 0.16
P/FCF ratio
18.89 17.97 38.15 13.31
P/Operating CF
19.33 (28.46) 45.65 20.59
P/B ratio
34.67 31.30 17.05 16.87
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.20 0.22 0.22 0.19
EV/EBITDA
17.28 19.22 18.58 15.46
EV/Operating CF
16.48 16.73 31.34 13.19
EV/FCF
19.92 19.66 44.52 15.48
Quick Ratio
0.51 0.47 0.48 0.48
Current Ratio
0.90 0.92 0.95 0.93
Net Debt/EBITDA
11.70 6.02 7.26 6.37
Debt/Assets
10.00% 10.11% 15.17% 13.99%
Debt/Equity
4.38 3.78 3.45 3.62
Asset Turnover
4.47 4.42 4.30 4.22
Operating CF/Net income
(9.22) (4.12) 0.82 3.48
Capex/Depreciation
(0.95) (0.29) (0.63) (0.81)
Interest Coverage
0.24 10.50 8.13 7.96
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2.09% 2.09% 2.52% 2.52%
Intangible Assets out of Total Assets
0.23 0.22 0.28 0.27
Share Based Compensation of Revenue
0.03% 0.08% 0.04% 0.03%
Graham Net Nets
(0.37) (0.34) (0.41) (0.46)
Graham Number
40.33 45.11 73.75 71.42
Earnings Yield
2.57% 2.48% 4.18% 4.78%
Free Cash Flow Yield
5.29% 5.56% 2.62% 7.51%
Revenue per Share
431.99 442.45 402.77 438.81
Operating CF per Share
16.17 (11.87) 6.88 13.74
Capex per Share
(1.29) (0.39) (0.85) (1.16)
Free Cash Flow per Share
14.88 (12.26) 6.03 12.58
Cash per Share
22.48 9.03 11.19 14.58
Shareholders Equity per Share
9.01 10.79 18.43 16.77
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
9.01 10.79 18.43 16.77
Free Cash Flow
2,883.61 (2,381.49) 1,173.74 2,430.06
Working Capital
(5,581.47) (4,980.57) (2,991.38) (3,861.96)
Capital Expenditures
(249.81) (76.32) (164.90) (224.00)
Net Current Asset Value
(22,603.95) (22,113.67) (24,926.24) (25,231.32)
EV/EBIT
24.30 26.75 25.57 20.90
Capex to Sales
0.00 0.00 0.00 0.00
Price to Operating Income
23.04 24.45 21.91 17.97
Other line items
Average Receivables
24,548.56 25,262.82 24,304.12 25,004.92
Average Payables
52,830.96 52,987.34 50,996.19 52,871.84
Average Inventory
19,745.66 22,293.26 19,487.76 20,584.10
Average Assets
71,845.89 73,707.76 76,422.99 78,881.23
Average Common Equity
1,266.91 1,228.93 2,382.38 2,724.49

Fold the line items

Columns are period end dates